Finch Therapeutics Group analyst ratings
Finch Therapeutics Group analyst ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2022 | 605.39% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
| 04/04/2022 | 605.39% | Jefferies | $29 → $17 | Maintains | Buy |
| 04/13/2021 | 1310.79% | Evercore ISI Group | → $34 | Initiates Coverage On | → Outperform |
| 04/13/2021 | 1103.32% | Jefferies | → $29 | Initiates Coverage On | → Buy |
| 04/13/2021 | 937.34% | B of A Securities | → $25 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/09/2022 | 605.39% | HC Wainwright & Co. | → 17 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2022 年 4 月 4 日 | 605.39% | 傑富瑞集團 | 29 美元 → 17 美元 | 維護 | 買 |
| 04/13/2021 | 1310.79% | Evercore ISI 集團 | → 34 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 04/13/2021 | 1103.32% | 傑富瑞集團 | → 29 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/13/2021 | 937.34% | B of A 類證券 | → 25 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Finch Therapeutics Group Questions & Answers
芬奇療法集團問題與解答
The latest price target for Finch Therapeutics Group (NASDAQ: FNCH) was reported by HC Wainwright & Co. on August 9, 2022. The analyst firm set a price target for $17.00 expecting FNCH to rise to within 12 months (a possible 605.39% upside). 2 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2022年8月9日公佈了芬奇療法集團（納斯達克股票代碼：FNCH）的最新目標股價。該分析公司將目標股價定爲17.00美元，預計FNCH將在12個月內升至12個月內（可能上漲605.39％）。去年有兩家分析公司公佈了評級。
The latest analyst rating for Finch Therapeutics Group (NASDAQ: FNCH) was provided by HC Wainwright & Co., and Finch Therapeutics Group initiated their buy rating.
Finch Therapeutics Group（納斯達克股票代碼：FNCH）的最新分析師評級由HC Wainwright & Co. 提供，Finch Therapeutics Group啓動了買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Finch Therapeutics Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Finch Therapeutics Group was filed on August 9, 2022 so you should expect the next rating to be made available sometime around August 9, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Finch Therapeutics Group的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Finch Therapeutics Group的最新評級是在2022年8月9日發佈的，因此您應該預計下一個評級將在2023年8月9日左右公佈。
While ratings are subjective and will change, the latest Finch Therapeutics Group (FNCH) rating was a initiated with a price target of $0.00 to $17.00. The current price Finch Therapeutics Group (FNCH) is trading at is $2.41, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但Finch Therapeutics Group（FNCH）的最新評級是首次提出，目標股價爲0.00美元至17.00美元。Finch Therapeutics Group（FNCH）目前的交易價格爲2.41美元，在分析師的預測區間內。